Comparison of Anti-SARS-CoV-2 IgG Antibody Responses Generated by the Administration of Ad26.COV2.S, AZD1222, BNT162b2, or CoronaVac: Longitudinal Prospective Cohort Study in the Colombian Population, 2021/2022

To mitigate the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), vaccines have been rapidly developed and introduced in many countries. In Colombia, the population was vaccinated with four vaccines. Therefore, this research aimed to...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Jeadran Malagón-Rojas, Marcela Mercado-Reyes, Yesith G. Toloza-Pérez, Marisol Galindo, Ruth M. Palma, Jenssy Catama, Juan F. Bedoya, Eliana L. Parra-Barrera, Ximena Meneses, Juliana Barbosa, Pilar Tavera-Rodríguez, Andrea Bermúdez-Forero, Martha Lucía Ospina-Martínez
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	MDPI AG 2022-09-01
Seri Bilgileri:	Vaccines
Konular:	COVID-19 SARS-CoV-2 cohort vaccine Colombia
Online Erişim:	https://www.mdpi.com/2076-393X/10/10/1609
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!